da Martina Zanero | Ott 6, 2025 | News
Watch this video to learn more about the vision behind the Saturn TMVR from CEO David Wilson, Founder and CTO Giovanni Righini, and VP Quality Daniele Marziantonio. We are grateful to ENEA Tech e Biomedical for helping drive the clinical development of Saturn TMVR...
da Martina Zanero | Set 4, 2025 | News
JACC Case Reports published the first report of a patient with the SATURN Trans-septal System in the CASSINI EU Early Feasibility Study. A 66-year-old woman with 3+ symptomatic MR patient underwent treatment with the fully percutaneous, transfemoral, transseptal...
da Martina Zanero | Lug 8, 2025 | News
At New York Valves on Friday, June 27th, Dr. Torsten Vahl from Columbia University Irving Medical Center gave an overview of the CASSINI-EU EFS study on Saturn Trans-septal TMVR System, focusing on the one year follow up of the first Trans-septal patient. The...
da Martina Zanero | Nov 12, 2024 | News
At TCT2024 on Tuesday, October 29, Dr. Torsten Vahl from Columbia University Irving Medical Center reviewed the first 3 patients in CASSINI-EU EFS study on Saturn Trans-septal TMVR System in the presentation ‘Novel TMVR Systems on the Launchpad’ during ‘TCT Innovation...
da Martina Zanero | Ago 8, 2024 | News
Annals of Thoracic Surgery Short Reports just published Early Feasibility Study with the SATURN Transapical Mitral Valve Replacement Device, available at https://doi.org/10.1016/j.atssr.2024.06.011. Deep gratitude and congratulation to the authors: Prof. Kęstutis...
da Martina Zanero | Giu 17, 2024 | News
Our technology and first trans-septal implant have been presented at NY Valves 2024 held on June 5-7 in Jacob K. Javits Convention Center, New York. Specifically, Dr. Lauren S. Ranard, MD from Columbia University Irving Medical Center, held a presentation named...
